GLABF (Gemina Laboratories) EBIT per Share: $-0.03 (TTM As of Oct. 2025)


What is Gemina Laboratories EBIT per Share?

Gemina Laboratories GLABF -27.59% EBIT per Share is $-0.03 as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's EBIT per Share for the three months ended in Oct. 2025 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Oct. 2025 was $-0.03.

During the past 3 years, the average EBIT per Share Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Gemina Laboratories's EBIT per Share or its related term are showing as below:

GLABF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 18.8   Med: 18.8   Max: 18.8
Current: 18.8

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Gemina Laboratories was 18.80% per year. The lowest was 18.80% per year. And the median was 18.80% per year.

GLABF's 3-Year EBIT Growth Rate is not ranked
in the Biotechnology industry.
Industry Median: 15.5 vs GLABF: 18.80

Gemina Laboratories's EBIT for the three months ended in Oct. 2025 was $-0.24 Mil.

Gemina Laboratories  (OTCPK:GLABF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Gemina Laboratories EBIT per Share Related Terms

Gemina Laboratories EBIT per Share Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories EBIT per Share Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
EBIT per Share
0.00 -0.08 -0.07 -0.05 -0.04

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.00 -0.00

Gemina Laboratories EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Gemina Laboratories's EBIT per Share for the fiscal year that ended in Jan. 2025 is calculated as

EBIT per Share(A: Jan. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.717/74.060
=-0.04

Gemina Laboratories's EBIT per Share for the quarter that ended in Oct. 2025 is calculated as

EBIT per Share(Q: Oct. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.239/76.571
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.03 mean?
Gemina Laboratories (GLABF) has a EBIT per Share of $-0.03 as of Oct. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' EBIT per Share too high?
Gemina Laboratories' current EBIT per Share is $-0.03.
How does Gemina Laboratories' EBIT per Share compare to VRTX and REGN?
Gemina Laboratories' EBIT per Share of $-0.03 can be compared against companies in the Biotechnology industry. The industry median EBIT per Share is 15.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.50, based on 1,181 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Gemina Laboratories and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gemina Laboratories's current EBIT per Share is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current EBIT per Share of $-0.03. The current EBIT per Share is $-0.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current EBIT per Share is $-0.03 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.